| Transitions Hospice Llc 1439 East Broadway, Bolivar, MO, 65613 | |
| (417) 777-2703 |
News Archive
A recent research study showed that for 16 COVID19 positive women there were evidences that their placentas had blood clots and indications of abnormal blood flow from the mother to the baby with most of the women having normal pregnancies.
Oxygen Biotherapeutics, Inc. has announced that the company has developed a gel-like form of Oxycyte that it intends to investigate as a topical application for open wounds, abrasions and burns. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
There's a lot you can do to reduce your risk of heart disease and improve your chances for a longer, healthier life. Cardiologists from The Polyclinic in Seattle recommend that you first, learn more about some of the risk factors for heart disease.
› Verified 9 days ago
| Name | Transitions Hospice Llc |
|---|---|
| Location | 1439 East Broadway, Bolivar, Missouri |
| Hospice ID | 261630 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Partnership |
| Profit Type | FOR PROFIT |
| SSA county code | 821 |
News Archive
A recent research study showed that for 16 COVID19 positive women there were evidences that their placentas had blood clots and indications of abnormal blood flow from the mother to the baby with most of the women having normal pregnancies.
Oxygen Biotherapeutics, Inc. has announced that the company has developed a gel-like form of Oxycyte that it intends to investigate as a topical application for open wounds, abrasions and burns. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
There's a lot you can do to reduce your risk of heart disease and improve your chances for a longer, healthier life. Cardiologists from The Polyclinic in Seattle recommend that you first, learn more about some of the risk factors for heart disease.
› Verified 9 days ago
| NPI Number | 1174699003 |
| Organization Name | Transitions Hospice, Llc |
| Address | 315 S Main Ave Bolivar, Missouri, 65613 |
| Phone Number | (417)777-2703 |
News Archive
A recent research study showed that for 16 COVID19 positive women there were evidences that their placentas had blood clots and indications of abnormal blood flow from the mother to the baby with most of the women having normal pregnancies.
Oxygen Biotherapeutics, Inc. has announced that the company has developed a gel-like form of Oxycyte that it intends to investigate as a topical application for open wounds, abrasions and burns. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
There's a lot you can do to reduce your risk of heart disease and improve your chances for a longer, healthier life. Cardiologists from The Polyclinic in Seattle recommend that you first, learn more about some of the risk factors for heart disease.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 95.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 96.8 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 95.1 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
A recent research study showed that for 16 COVID19 positive women there were evidences that their placentas had blood clots and indications of abnormal blood flow from the mother to the baby with most of the women having normal pregnancies.
Oxygen Biotherapeutics, Inc. has announced that the company has developed a gel-like form of Oxycyte that it intends to investigate as a topical application for open wounds, abrasions and burns. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
There's a lot you can do to reduce your risk of heart disease and improve your chances for a longer, healthier life. Cardiologists from The Polyclinic in Seattle recommend that you first, learn more about some of the risk factors for heart disease.
› Verified 9 days ago
| Home Health Aides | 1.5 |
| Counselors | 0.5 |
| Homemakers | 1.5 |
| Medical Social Workers | 0.75 |
| Physicians | 0.25 |
| Registered Nurses | 2.25 |
| Other Personnel | 0.75 |
| Total Employees | 7.5 |
|---|
News Archive
A recent research study showed that for 16 COVID19 positive women there were evidences that their placentas had blood clots and indications of abnormal blood flow from the mother to the baby with most of the women having normal pregnancies.
Oxygen Biotherapeutics, Inc. has announced that the company has developed a gel-like form of Oxycyte that it intends to investigate as a topical application for open wounds, abrasions and burns. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
There's a lot you can do to reduce your risk of heart disease and improve your chances for a longer, healthier life. Cardiologists from The Polyclinic in Seattle recommend that you first, learn more about some of the risk factors for heart disease.
› Verified 9 days ago
| Citizens Memorial Hospice Location: 1500 North Oakland, Bolivar, Missouri, 65613 Phone: (417) 777-2703 |
| Transitions Hospice Llc Location: 1439 East Broadway, Bolivar, Missouri, 65613 Phone: (417) 777-2703 |